PRZOOM - /newswire/ -
San Antonio, TX, United States, 2007/02/06 - New analysis from Frost & Sullivan, U.S. Artificial Heart Valve Markets, reveals that revenues in this market totaled $519 million in 2005, and can reach $867 million in 2012.
– While artificial heart valves have been in existence since 1950s, the past several years have seen significant upgrades in the materials and methodologies used in those devices.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Artificial Heart Valve Markets, then send an e-mail to Melina Trevino - Corporate Communications with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.
“Recent advances in catheter technology have renewed focus on repair over replacement,” notes Frost & Sullivan Research Analyst Venkat Rajan. “Therefore, given the added physiological limitations of certain replacement valves, the majority of start up activity has been focused on the development of tissue valve repair products.”
Improvements to minimally invasive technologies and the rising prevalence of congestive heart failure and valve regurgitation have spurred a rise in the number of entrepreneurial annuloplasty designers. In the past an open heart procedure for heart valve was almost as risky as performing a valve replacement, therefore limiting application. However, with the introduction of minimally invasive beating heart products, heart valve repair has become a more feasible option.
Nevertheless, one of the biggest challenges to grow in a mature industry is executing strategies with enough magnitude to instigate a significant shift in the market. In nascent or developing medical device fields, a new product with advanced features or improved procedural efficiency is enough to warrant rapid market adoption. In mature markets such as this one, the opportunities to shift market perception about one’s brand name or a technology are quite limited.
“Growth in the U.S. heart valve market is being restrained by the absence of any recent paradigm shifting technologies that could otherwise facilitate market expansion,” says Rajan. “Another common barrier for growth is the regulatory and reimbursement requirements for defining qualified patients for interventional therapy.”
Given the importance placed on evidence-based medicine, it is crucial that market participants be able to profile their devices with detailed early stage and post market launch clinical data. Device thrombosis and durability are the biggest factors that affect device selection among clinicians, and being able to show low rates of complications requiring follow-up procedures are critical to persuading device adoption. Moreover, in established markets where there are no external threats, such as those for heart valves, head-to-head trials versus market competitors’ devices can be effective in shifting market share within a short time period.
U.S. Artificial Heart Valve Markets is part of the Medical Devices subscription, which also includes research services in the following markets: U.S. carotid and intracranial devices, U.S. cardiac rhythm management market and U.S. congestive heart failure devices market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership service, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.